RMAT – New Economy World

Tuesday, February 11, 2025

Immix Biopharma Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for NXC-201, sterically-optimized CAR-T for relapsed/refractory AL Amyloidosis

10/02/2025

Immix Biopharma Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for NXC-201, sterically-optimized CAR-T for relapsed/refractory…

Tag: RMAT

Immix Biopharma Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for NXC-201, sterically-optimized CAR-T for relapsed/refractory AL Amyloidosis

Management restructure at Balfour Beatty to target growth markets

Two senior partners are leaving Peak XV amid strategy shift

A Closer Look At Full-Time And Part-Time Employment: January 2025

Australia's Macquarie joins major US banks in exiting global climate coalition

SiTime Corporation: Why There May Be Second Guessing Of The AI Thesis

Consultants called for £175m franework

CROCS SECURITIES FRAUD NOTICE: Berger Montague Informs Crocs (CROX) Investors of a Securities Fraud Lawsuit

Management restructure at Balfour Beatty to target growth markets

Two senior partners are leaving Peak XV amid strategy shift

Management restructure at Balfour Beatty to target growth markets

Two senior partners are leaving Peak XV amid strategy shift

Management restructure at Balfour Beatty to target growth markets

Two senior partners are leaving Peak XV amid strategy shift